An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells

Urology

Volumn 60, Issue 3, 2002, Pages 521-526

  Schmidhammer, Silvia ^a   Ramoner, Reinhold ^a   Höltl, Lorenz ^a   Bartsch, Georg ^a   Thurnher, Martin ^a   Zelle Rieser, Claudia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; ESCHERICHIA COLI VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; UROVAXOM;

ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CELL SORTER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; DRUG POTENCY; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MIXED LYMPHOCYTE REACTION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; URINARY TRACT INFECTION;

EID: 0036754578     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01767-3     Document Type: Article

References (32)

1. Barnett B.J., Stephens D.S. Urinary tract infection an overview . Am J Med Sci. 314:1997;245-249.
2. Fayette J., Dubois B., Vandenabeele S., et al. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med. 185:1997;1909-1918.
3. Neutra M.R., Frey A., Kraehenbuhl J.P. Epithelial M cells gateways for mucosal infection and immunization . Cell. 86:1996;345-348.
4. Ruedl C., Wolf H. Features of oral immunization. Int Arch Allergy Immunol. 108:1995;334-339.
5. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
6. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179:1994;1109-1118.
7. Cella M., Scheidegger D., Palmer-Lehmann K., et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity T-T help via APC activation . J Exp Med. 184:1996;747-752.
8. Cella M., Engering A., Pinet V., et al. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:1997;782-787.
9. Sallusto F., Palermo B., Lenig D., et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol. 29:1999;1617-1625.
10. Steinman R.M. Dendritic cells and the control of immunity enhancing the efficiency of antigen presentation . Mt Sinai J Med. 68:2001;106-166.
11. 2 and tumor necrosis factor alpha cooperate to activate human dendritic cells synergistic activation of interleukin 12 production . J Exp Med. 186:1997;1603-1608.
12. Verhasselt V., Buelens C., Willems F., et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells evidence for a soluble CD14-dependent pathway . J Immunol. 158:1997;2919-2925.
13. Jungi T.W., Brcic M.E., Eperon S. Human macrophages respond to LPS in a serum-independent, CD14-dependent manner. Immunol Lett. 54:1996;37-43.
14. Cella M., Salio M., Sakakibara Y., et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med. 189:1999;821-829.
15. Thurner B., Haendle I., Roder C., et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med. 190:1999;1669-1678.
16. Rieser C., Ramoner R., Höltl L., et al. Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma. Urol Int. 63:1999;151-159.
17. Höltl L., Rieser C., Papesh C., et al. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol. 161:1999;777-782.
18. Höltl L., Rieser C., Papesh C., et al. CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer. Lancet. 352:1998;1358.
19. Nishiyama T., Tachibana M., Horiguchi Y., et al. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide. Clin Cancer Res. 7:2001;23-31.
20. Burch P.A., Breen J.K., Buckner J.C., et al. Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. Clin Cancer Res. 6:2000;2175-2182.
21. Morse M.A., Deng Y., Coleman D., et al. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res. 5:1999;1331-1338.
22. Banchereau J., Palucka A.K., Dhodapkar M., et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 61:2001;6451-6458.
23. Sadanaga N., Nagashima H., Mashino K., et al. Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res. 7:2001;2277-2284.
24. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 1:2000;199-205.
25. 2 . Blood. 91:1998;3112-3117.
26. Spalding D.M., Koopman W.J., Eldridge J.H., et al. Accessory cells in murine Peyer's patch. I. Identification and enrichment of a functional dendritic cell. J Exp Med. 157:1983;1646-1659.
27. Schrader C.E., George A., Kerlin R.L., et al. Dendritic cells support production of IgA and other non-IgM isotypes in clonal microculture. Int Immunol. 2:1990;563-570.
28. MacPherson G.G., Liu L.M. Dendritic cells and Langerhans cells in the uptake of mucosal antigens. Curr Top Microbiol Immunol. 236:1999;33-53.
29. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 12:1994;991-1045.
30. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med. 176:1992;1355-1364.
31. Höltl L, Zelle-Rieser C, Gander H, et al: Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res (in press).
32. Uehling D.T., Johnson D.B., Hopkins W.J. The urinary tract response to entry of pathogens. World J Urol. 17:1999;351-358.